最近の論文

印刷

  • HOME
  • 最近の論文

最近の論文

2020年 | 2019年 | 2018年 | 2017年 | 2016年 | 2015年 | 2014年 | 2013年

Takahashi, K., Seto, Y., Okada, K., Uematsu, S., uchibori, K., Tsukahara, M., Oh-hara, T., Fujita, N., Yanagitani, N., Nishio, M., Okubo, K. and Katayama, R.
Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non-small cell lung cancer.
Thorac. Cancer, in press (2020)
Kawakami, R., Mashima, T., Kawata, N., Kumagai, K., Migita, T., Sano, T., Mizunuma, N., Yamaguchi, K. and Seimiya, H.
ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancer.
Cancer Sci., in press (2020)
Jang, M. K., Mashima, T. and Seimiya, H.
Tankyrase inhibitors target colorectal cancer stem cells via AXIN-dependent downregulation of c-KIT tyrosine kinase.
Mol. Cancer Ther., in press (2020)
Tanaka, N., Takahara, A., Hagio, T., Nishiko, R., Kanayama, J., Gotoh, O. and Mori, S.
Sequencing artifacts derived from a library preparation method using enzymatic fragmentation.
PLoS One, 15, e0227427 (2020)
Mizutani, A. and Seimiya, H.
Tankyrase promotes primary precursor miRNA processing to precursor miRNA.
Biochem. Biophys. Res. Commun., in press (2019)
Luangxay, T., Osako, T., Yonekura, R., Sugiura, Y., Kikuchi, M., Gomi, N., Ueno, T., Ohno, S., Machinami, R., Takeuchi, K. and Akiyama, F.
Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literature.
Pathobiology Reseach and Practice, in press (2019)
Goto, O., Sugiyama, Y., Takazawa, Y., Kato, K., Tanaka, N., Omatsu, K., Takeshima, N., Nomura, H., Hasegawa, K., Fujiwara, K., Taki, M., Matsumura, N., Noda, T. and Mori, S.
Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma.
Nat. Commun., 10, 4965 (2019)
Sugiyama, Y., Gotoh, O., Fukui, N., Tanaka, N., Hasumi, K., Takazawa, Y., Noda, T. and Mori, S.
Two distinct tumorigenic processes in endometrial endometrioid adenocarcinoma.
Am. J. Pathol., in press (2019)
Mashima, T., Iwasaki, R., Kawata, N., Kawakami, R., Kumagai, K., Migita, T., Sano, T., Yamaguchi, K. and Seimiya, H.
In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.
Br. J. Cancer., in press (2019)
Udagawa, C., Horinouchi, H., Shiraishi, K., Kohno, T., Okusaka, T., Ueno, H., Tamura, K., Ohe, Y. and Zembutsu, H.
Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease.
PLoS One, in press (2019)

このページのTOPへ